Human Kidney Cancer Tissue Lysates
Pricing |
Normal Lysates: $125/100 ug |
Tumor Lysates: $175/100 ug |
Nor./Tum. set: $270.00 (10% off) |
Discounts |
2-8 Vials 10% |
9-20 Vials 15% |
>20 Vials 20% |
Introduction:
Histologic types of kidney cancer include the following:
Approximately 85% of renal cell cancers are adenocarcinomas, and most of those are of proximal tubular origin. Most of the remainder are transitional cell carcinomas of the renal pelvis (refer to the PDQ summary on Transitional Cell Cancer of the Renal Pelvis and Ureter Treatment for more information). Adenocarcinomas may be separated into clear cell and granular cell carcinomas; however, the 2 cell types may occur together in some tumors. Some investigators have found that granular cell tumors have a worse prognosis, but this finding is not universal. The distinction between well-differentiated renal adenocarcinomas and renal adenomas can be difficult. The diagnosis is usually made arbitrarily on the basis of size of the mass, but size alone should not influence the treatment approach, since metastases can occur with lesions as small as 0.5 centimeters.
Human Kidney Cancer Lysates | ||||||
Catalog Number |
Diagnosis |
Grade |
Stage |
TNM |
Sex |
Age |
Papillary renal cell carcinoma |
1 |
n/a |
n/a |
M |
56 |
|
Renal clear cell carcinoma |
1 |
n/a |
n/a |
F |
40 |
|
Papillary renal cell carcinoma |
1 |
n/a |
n/a |
M |
65 |
|
Renal clear cell carcinoma |
1 |
II |
T2N0M0 |
F |
48 |
|
Renal clear cell carcinoma |
1 |
II |
T3N0M0 |
F |
62 |
|
Renal clear cell carcinoma |
2 |
II |
n/a |
F |
69 |
|
Renal clear cell carcinoma |
3 |
III |
T2N0Mx |
M |
57 |
|
Renal clear cell carcinoma |
3 |
III |
T3bN0Mx |
F |
44 |
|
Renal clear cell carcinoma |
n/a |
n/a |
n/a |
F |
42 |
|
Renal cysts |
n/a |
n/a |
n/a |
M |
82 |
|
Renal clear cell carcinoma |
n/a |
n/a |
n/a |
F |
39 |
|
Renal clear cell carcinoma |
n/a |
n/a |
n/a |
F |
41 |
|
Renal clear cell carcinoma |
n/a |
n/a |
n/a |
M |
4 |
|
Renal clear cell carcinoma |
n/a |
II |
n/a |
M |
60 |
|
Renal clear cell carcinoma |
n/a |
II |
n/a |
M |
29 |
|
Renal clear cell carcinoma |
n/a |
II |
n/a |
M |
64 |
|
Renal clear cell carcinoma |
3 |
II |
n/a |
M |
45 |
|
Transitional cell carcinoma |
2 |
II |
T2N0M0 |
M |
42 |
|
Adenocarcinoma |
3 |
II |
T2N0M0 |
M |
37 |
|
T11-024 | Renal clear cell carcinoma |
1 |
n/a |
n/a |
F |
37 |
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
69 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
F |
60 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
II |
T2N0M0 |
F |
60 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
70 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
53 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
F |
59 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
71 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
68 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
57 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
54 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
39 |
|
Clear cell carcinoma, well differentiated. |
1 |
III |
T2N0M0 |
M |
49 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
I |
T1bN0M0 |
M |
60 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
I |
T1N0M0 |
F |
48 |
|
Clear cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
F |
60 |
|
Renal cell carcinoma, poorly differentiated. |
3 |
II |
T2N0M0 |
F |
52 |
|
Renal cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
88 |
|
Transitional cell carcinoma. |
2 |
n/a |
n/a |
M |
48 |
|
Transitional cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
F |
64 |
|
Transitional cell carcinoma, poorly differentiated. |
3 |
n/a |
n/a |
M |
58 |
|
Renal granular cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
M |
41 |
|
Papillary renal cell carcinoma, moderately differentiated. |
2 |
n/a |
n/a |
F |
31 |
|
Adenocarcinoma, poorly differentiated. |
3 |
n/a |
T4N1M0 |
F |
71 |
|
Sarcoma, moderately differentiated. |
2 |
II |
T2N0M0 |
F |
30 |
References:
Mostofi FK, Davis CJ, Sesterhenn IA: Pathology of tumors of the urinary tract. In: Skinner DG, Lieskovsky G, eds.: Diagnosis and Management of Genitourinary Cancer. Philadelphia, Pa: WB Saunders, 1988., pp 83-117.
Wilson TG, Pritchett TR, Lieskovsky G, et al.: Primary adenocarcinoma of bladder. Urology 38 (3): 223-6, 1991.
LiVolsi VA: Pathology of thyroid disease. In: Falk SA: Thyroid Disease: Endocrinology, Surgery, Nuclear Medicine, and Radiotherapy. Philadelphia, PA: Lippincott-Raven, 1997., pp 127-175.